https://www.selleckchem.com/pr....oducts/crenolanib-cp
UK primary-care referral guidance describes the signs, symptoms, and test results ("features" of undiagnosed cancer. Guidance revision in 2015 liberalised investigation by introducing more low-risk features. We studied adults with cancer whose features were in the 2005 guidance ("Old-NICE" or were introduced in the revision ("New-NICE". We compared time to diagnosis between the groups, and its trend over 2006-2017. Clinical Practice Research Datalink records were analysed for adults with incident myeloma, breast, bladder
Like
Comment
Share
